Clinical Trials Directory

Trials / Completed

CompletedNCT00217243

Evoked Fields After Median and Ulnar Stimulation

Evoked (Magnetic) Cortical Fields for the Comparative Study of Mechanisms Underlying Chronic Non-malignant Pain in Peripheral Nerve Injury (CRPS II) and CRPS I (Chronic Regional Pain Syndrome I)

Status
Completed
Phase
Study type
Observational
Enrollment
60 (actual)
Sponsor
Medical Center Alkmaar · Academic / Other
Sex
All
Age
17 Years – 70 Years
Healthy volunteers
Accepted

Summary

In order to be able to study the effects of evoked fields with magnetoencephalography (MEG) in two groups of patients, comparison is made with a group of healthy volunteers.

Detailed description

This study is directed at the (central and / or peripheral) mechanisms of pain and the cortical changes (plasticity) due to chronic non-malignant pain in two groups of patients and one healthy volunteer group. The aim of the study is further to evaluate cortical processes by MEG (and fMRI, if feasible) to quantify and qualify the responses, localise the generators and study the effects of a pain therapy. To search for patterns that may result in diagnostic criteria and have an indicative value for the treatment and the monitoring of the effects. Finally the study not only intends to support clinical diagnosis but also to provide tools to monitor treatment and support the choice (algorithm) between SCS and SAN. An algorithm, facilitating decision making between these two treatments, will be promoted. It should also provide a clinical decision tool for the use of SAN

Conditions

Interventions

TypeNameDescription
OTHEREvoked fields before and after a local block (Xylocaine)MEG registration after electrical median and ulnar nerve stimulation in subjects and patients. In the patient group another MEG was performed after an anaesthetic block (1-2 ml Lidocaine 1%) at the site of the nerve injury producing a painfree state

Timeline

Start date
2005-06-01
Completion
2007-06-01
First posted
2005-09-22
Last updated
2009-09-18

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT00217243. Inclusion in this directory is not an endorsement.